Weight Loss Following Liraglutide Therapy in a Patient With Smith-Magenis Syndrome: A Case Report

Dave K Garg, Jeffrey Wei · 2026

Read Weight Loss Following Liraglutide Therapy in a Patient With Smith-Magenis Syndrome: A Case Report by Dave K Garg, Jeffrey Wei (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13391223.txt.

Description

Dave K Garg and Jeffrey Wei report, in 2026, substantial weight loss with a daily diabetes injection in a young man with a rare genetic obesity syndrome. Smith-Magenis syndrome drove excessive hunger and rapid weight gain despite portion control and behaviour support over five years.

With prediabetes, abnormal lipids, and fatty liver emerging, the team started liraglutide, a GLP-1 receptor agonist, and raised it gradually to the maximum dose over five months. The patient tolerated it without severe stomach side effects and, with lifestyle support, lost a large amount of weight over eleven months. Endocrine readers gain a single-case signal that appetite-targeting drugs can work even when obesity has a strong genetic driver.

Catalog record

CREATORDave K Garg, Jeffrey Wei
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE17086
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13391223

Browse the full library · About the Tower of Babel